Enovis Corp. (ENOV)
27.82
+0.15
(+0.54%)
USD |
NYSE |
Dec 11, 16:00
27.82
0.00 (0.00%)
After-Hours: 20:00
Enovis Free Cash Flow: 22.76M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Baxter International, Inc. | 235.00M |
| Integra LifeSciences Holdings Corp. | -14.47M |
| Merit Medical Systems, Inc. | 203.79M |
| Repligen Corp. | 103.47M |
| Perspective Therapeutics, Inc. | -106.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 82.58M |
| Cash from Investing (Quarterly) | -56.06M |
| Cash from Financing (Quarterly) | -36.91M |
| Free Cash Flow Per Share (Quarterly) | 0.5088 |
| Free Cash Flow to Equity (Quarterly) | 52.60M |
| Free Cash Flow to Firm (Quarterly) | 50.06M |
| Free Cash Flow Yield | 1.44% |